share_log

Needham Maintains Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Needham Maintains Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Needham 維持對Phathom Pharmicals的買入,維持26美元的目標股價
Moomoo 24/7 ·  03/15 10:34

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

尼德姆分析師約瑟夫·斯金格維持Phathom Pharmicals(納斯達克股票代碼:PHAT)的買入並維持26美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論